4.7 Article

Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Article Infectious Diseases

Reflections on the 2021 World Malaria Report and the future of malaria control

April Monroe et al.

Summary: The World Malaria Report 2021 highlights the unique challenges faced by the global malaria community, revealing the underestimation of disease burden and the severity of the malaria crisis in Africa. The disruptions caused by the COVID-19 pandemic exposed the weaknesses of health systems and inadequate financing, limiting the capacity of African countries to address malaria.

MALARIA JOURNAL (2022)

Article Immunology

Pseudomonas aeruginosa Infection Modulates the Immune Response and Increases Mice Resistance to Cryptococcus gattii

Eluzia C. Peres-Emidio et al.

Summary: This study investigated the interaction between Cryptococcus and Pseudomonas aeruginosa (Pa), and found that Pa inhibited the growth of Cryptococcus in vitro and enhanced the fungicidal activity of macrophages. In in vivo experiments, previous Pa infection reduced the severity and lethality of cryptococcosis, possibly by decreasing the fungal burden in the lungs and brain and inducing inflammation. The results suggest that Pa plays an important protective role in coinfections.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Pharmacology & Pharmacy

Oteseconazole: First Approval

Sheridan M. Hoy

Summary: Oteseconazole is an orally administered azole antifungal agent that inhibits fungal cell membrane formation and integrity. It is the first drug approved for reducing the incidence of recurrent vulvovaginal candidiasis (RVVC) in the USA. Clinical development for the treatment of onychomycosis, invasive, and opportunistic infections is ongoing.
Editorial Material Public, Environmental & Occupational Health

Moving mycoses up the global agenda

[Anonymous]

LANCET GLOBAL HEALTH (2022)

Correction Biochemistry & Molecular Biology

SynergyFinder 2.0: visual analytics of multi-drug combination synergies (vol 48, pg W88, 2020)

A. Ianevski

NUCLEIC ACIDS RESEARCH (2022)

Review Dermatology

Epidemiology of Cryptococcus and cryptococcosis in Western Africa

Chidinma Lynda Akaihe et al.

Summary: Cryptococcosis is a serious fungal disease predominantly affecting individuals with weakened immune systems, potentially making West Africa a hotspot for the disease. Clinical symptoms include chest pain, headache, and nausea. Data on the prevalence of the disease in West Africa is limited, highlighting the need for further research in the region.

MYCOSES (2021)

Review Immunology

Antifungal Pipeline

Todd Patrick McCarty et al.

Summary: Fungal diseases have been overlooked or neglected, with anti-bacterial agents receiving more attention in recent decades. However, there is now a growing focus on developing new antifungal medications to combat rising resistance and emerging organisms. It is hoped that in the future, more novel antifungal agents will come to market to assist physicians in treating various fungal infections.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Infectious Diseases

Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis

Noelly Queiroz Ribeiro et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Endocrinology & Metabolism

Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice

Hoe-Yune Jung et al.

DIABETES OBESITY & METABOLISM (2018)

Article Microbiology

FungiDB: An Integrated Bioinformatic Resource for Fungi and Oomycetes

Evelina Y. Basenko et al.

JOURNAL OF FUNGI (2018)

Review Cell Biology

Cryptococcal therapies and drug targets: the old, the new and the promising

Carolina Coelho et al.

CELLULAR MICROBIOLOGY (2016)

Article Microbiology

Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii

Gabriella Freitas Ferreira et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Genetics & Heredity

Cryptococcosis diagnosis and treatment: What do we know now

John R. Perfect et al.

FUNGAL GENETICS AND BIOLOGY (2015)

Article Multidisciplinary Sciences

Systematic functional profiling of transcription factor networks in Cryptococcus neoformans

Kwang-Woo Jung et al.

NATURE COMMUNICATIONS (2015)

Article Microbiology

Role of Cln1 during melanization of Cryptococcus neoformans

Rocio Garcia-Rodas et al.

FRONTIERS IN MICROBIOLOGY (2015)

Article Microbiology

Antimalarial Action of Artesunate Involves DNA Damage Mediated by Reactive Oxygen Species

Anusha M. Gopalakrishnan et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Infectious Diseases

Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms

Nicolas Delattin et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)

Article Infectious Diseases

The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii

Gabriella Freitas Ferreira et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)

Article Cell Biology

Fungicidal Drugs Induce a Common Oxidative-Damage Cellular Death Pathway

Peter Belenky et al.

CELL REPORTS (2013)

Editorial Material Pharmacology & Pharmacy

Drug Repurposing: Far Beyond New Targets for Old Drugs

T. I. Oprea et al.

AAPS JOURNAL (2012)

Article Microbiology

Dynamic Interaction between Fluconazole and Amphotericin B against Cryptococcus gattii

Julliana Ribeiro Alves Santos et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Article Microbiology

It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug

Ana C. Mesa-Arango et al.

Frontiers in Microbiology (2012)

Article Biochemistry & Molecular Biology

Dose translation from animal to human studies revisited

Shannon Reagan-Shaw et al.

FASEB JOURNAL (2008)

Article Microbiology

Voriconazole inhibits melanization in Cryptococcus neoformans

Luis R. Martinez et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)

Article Multidisciplinary Sciences

Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells

Thomas Efferth et al.

PLOS ONE (2007)

Article Pharmacology & Pharmacy

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo

SJF Kaptein et al.

ANTIVIRAL RESEARCH (2006)

Article Parasitology

Artemisinin: mechanisms of action, resistance and toxicity

SR Meshnick

INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)

Review Microbiology

Melanin and virulence in Cryptococcus neoformans

A Casadevall et al.

CURRENT OPINION IN MICROBIOLOGY (2000)